Accurate blood tests for Alzheimer’s disease (AD) are critical tools that have the potential to revolutionize dementia research, clinical trials and clinical care. Models combining blood-based biomarkers that represent multiple aspects of AD brain pathology with key individual level factors may improve prediction of AD dementia.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The impact of exercise on blood-based biomarkers of Alzheimer’s disease in cognitively unimpaired older adults
GeroScience Open Access 15 March 2024
-
Contextual Exceptionalism After Death: An Information Ethics Approach to Post-Mortem Privacy in Health Data Research
Science and Engineering Ethics Open Access 03 August 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nakamura, A. et al. Nature 554, 249–254 (2018).
Ovod, V. et al. Alzheimers. Dement. 13, 841–849 (2017).
Schindler, S. E. et al. Neurology 93, e1647–e1659 (2019).
Palmqvist, S. et al. JAMA 324, 772–781 (2020).
Mielke, M. M. et al. Alzheimers. Dement. 14, 989–997 (2018).
Barthelemy, N. R., Horie, K., Sato, C. & Bateman, R. J. J. Exp. Med. 217, e20200861 (2020).
Janelidze, S. et al. Nat. Med. 26, 379–386 (2020).
Karikari, T. K. et al. Lancet Neurol. 19, 422–433 (2020).
Preische, O. et al. Nat. Med. 25, 277–283 (2019).
Mattsson, N., Cullen, N. C., Andreasson, U., Zetterberg, H. & Blennow, K. JAMA Neurol. 76, 791–799 (2019).
Cullen, N. C. et al. Nat. Aging https://doi.org/10.1038/s43587-020-00003-5 (2020).
Karran, E. & Hardy, J. N. Engl. J. Med. 370, 377–378 (2014).
Bateman, R. J. & Klunk, W. E. Neurotherapeutics 5, 381–390 (2008).
Sperling, R. A. et al. Sci. Transl. Med. 6, 228fs213 (2014).
Rabinovici, G. D. et al. JAMA 321, 1286–1294 (2019).
Acknowledgements
S.E.S. is supported by National Institute on Aging (grant no. K23AG053426).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.J.B. co-founded C2N Diagnostics. Washington University and R.J.B. have equity ownership interest in C2N Diagnostics and receive royalty income based on technology (stable isotope labeling kinetics and blood plasma assay) licensed by Washington University to C2N Diagnostics. R.J.B. receives income from C2N Diagnostics for serving on the Scientific Advisory Board. Washington University, with R.J.B. as co-inventor, have filed patent applications (US Patent application nos. 16/610,428; 62/898,407; 62/962,296; PCT/US2020/012959) on technology related to the processes described in this article. R.J.B. has received honoraria as a speaker/consultant/advisory board member from Amgen, AC Immune, Eisai, F. Hoffman-LaRoche and Janssen, and reimbursement of travel expenses from AC Immune, F. Hoffman-La Roche and Janssen. S.E.S. declares no competing interests.
Rights and permissions
About this article
Cite this article
Schindler, S.E., Bateman, R.J. Combining blood-based biomarkers to predict risk for Alzheimer’s disease dementia. Nat Aging 1, 26–28 (2021). https://doi.org/10.1038/s43587-020-00008-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43587-020-00008-0
This article is cited by
-
The impact of exercise on blood-based biomarkers of Alzheimer’s disease in cognitively unimpaired older adults
GeroScience (2024)
-
Contextual Exceptionalism After Death: An Information Ethics Approach to Post-Mortem Privacy in Health Data Research
Science and Engineering Ethics (2022)